The evolution of immune checkpoint inhibitors

Date 28 March 2014
Event ELCC 2014
Session The potential of immunotherapy in NSCLC
Topics Non-Small-Cell Lung Cancer, Metastatic
Cancer Immunology and Immunotherapy
Presenter Roy S. Herbst
Authors R.S. Herbst
  • Medical Oncology, Yale Cancer Center, 06520 - New Haven/US